Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jun 22;277(1689):1777-87.
doi: 10.1098/rspb.2009.2176. Epub 2010 Mar 3.

DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery

Affiliations
Review

DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery

Carlos García-Estrada et al. Proc Biol Sci. .

Abstract

The phylum Apicomplexa includes a large group of protozoan parasites responsible for a wide range of animal and human diseases. Destructive pathogens, such as Plasmodium falciparum and Plasmodium vivax, causative agents of human malaria, Cryptosporidium parvum, responsible of childhood diarrhoea, and Toxoplasma gondii, responsible for miscarriages and abortions in humans, are frequently associated with HIV immunosuppression in AIDS patients. The lack of effective vaccines, along with years of increasing pressure to eradicate outbreaks with the use of drugs, has favoured the formation of multi-drug resistant strains in endemic areas. Almost all apicomplexan of medical interest contain two endosymbiotic organelles that contain their own mitochondrial and apicoplast DNA. Apicoplast is an attractive target for drug testing because in addition to harbouring singular metabolic pathways absent in the host, it also has its own transcription and translation machinery of bacterial origin. Accordingly, apicomplexan protozoa contain an interesting mixture of enzymes to unwind DNA from eukaryotic and prokaryotic origins. On the one hand, the main mechanism of DNA unwinding includes the scission of one-type I-or both DNA strands-type II eukaryotic topoisomerases, establishing transient covalent bonds with the scissile end. These enzymes are targeted by camptothecin and etoposide, respectively, two natural drugs whose semisynthetic derivatives are currently used in cancer chemotherapy. On the other hand, DNA gyrase is a bacterial-borne type II DNA topoisomerase that operates within the apicoplast and is effectively targeted by bacterial antibiotics like fluoroquinolones and aminocoumarins. The present review is an update on the new findings concerning topoisomerases in apicomplexan parasites and the role of these enzymes as targets for therapeutic agents.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(a) Phylogenetic tree carried out using the amino acid sequences of type I DNA topoisomerases from apicomplexan parasites and other organisms annotated into the GenBank database. (b) Same as (a), but using the amino acid sequences of type II DNA topoisomerases. (c) Same as (a,b), but using the amino acid sequences of DNA gyrases: (i) gyrA, (ii) gyrB. The phylograms are displayed on TreeView using the tree produced by Clustal W. The evolutionary scale bar is shown on the left; it indicates the relative distance on the tree in arbitrary units.

Similar articles

Cited by

References

    1. Anonymous 2000DNA topoisomerase II inhibitors. IARC Monogr. Eval. Carcinog. Risks Hum. 76, 175–344 - PMC - PubMed
    1. Aravind L., Leipe D. D., Koonin E. V.1998Toprim: a conserved catalytic domain in type IA and II topoisomerases, DNAG-type primases, OLD family nucleases and RecR proteins. Nucleic Acids Res. 26, 4205–4213 (doi:10.1093/nar/26.18.4205) - DOI - PMC - PubMed
    1. Auparakkitanon S., Wilairat P.2000Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in malaria parasite, Plasmodium falciparum. Biochem. Biophys. Res. Commun. 269, 406–409 (doi:10.1006/bbrc.2000.2305) - DOI - PubMed
    1. Balana-Fouce R., Redondo C. M., Perez-Pertejo Y., Diaz-Gonzalez R., Reguera R. M.2006Targeting atypical trypanosomatid DNA topoisomerase I. Drug Discov. Today 11, 733–740 (doi:10.1016/j.drudis.2006.06.014) - DOI - PubMed
    1. Bates A. D., Maxwell A.2007Energy coupling in type II topoisomerases: why do they hydrolyze ATP? Biochemistry 46, 7929–7941 (doi:10.1021/bi700789g) - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources